Skip to main content

RVL Pharmaceuticals plc

RVLPDelisted Nov 20, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001739426

RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding RVL Pharmaceuticals plc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of RVLP: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders5546−9
Shares7.88M4.83M−3.05M (−38.7%)
Value$25.7M$14.5M−$11.1M (−43.4%)

New holders (10)

Institutions that held RVL Pharmaceuticals plc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to RVLP in Q2 2021
InstitutionSharesValue% of portfolio
Rovida Advisors Inc.300,308$901.0K0.04%
Millennium Management LLC160,140$482.0K0.00%
Ergoteles LLC57,200$172.0K0.00%
HRT Financial LP36,061$108.0K0.00%
Jane Street Group, LLC35,028$105.0K0.00%
Credit Suisse AG27,966$84.0K0.00%
ExodusPoint Capital Management, LP12,077$36.0K0.00%
UBS Group AG1,699$5.00K0.00%
Mirae Asset Global Investments Co., Ltd.1,020$3.00K0.00%
Captrust Financial Advisors730$2.00K0.00%

Sold out (19)

Institutions that held RVL Pharmaceuticals plc at the end of Q1 2021 and filed for Q2 2021 without it.